| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |